Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of Tuesday, October 6, 2026.
EARNINGS PER SHARE (EPS)
N/A
Electra Therapeutics Inc.
Market Cap
$202.90M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$208.90M
Earnings Per Share (EPS)
4.12
TTM Avg
3.49
3Y Avg
2.39
5Y Avg
2.00
Market Cap
$211.27M
Earnings Per Share (EPS)
-1.10
TTM Avg
-1.31
3Y Avg
-1.45
5Y Avg
-1.45
Market Cap
$193.36M
Earnings Per Share (EPS)
-0.99
TTM Avg
-0.66
3Y Avg
-3.05
5Y Avg
-5.28
Market Cap
$214.45M
Earnings Per Share (EPS)
0.19
TTM Avg
0.17
3Y Avg
0.00
5Y Avg
-0.12
Market Cap
$215.11M
Earnings Per Share (EPS)
0.38
TTM Avg
0.11
3Y Avg
-0.10
5Y Avg
-0.19
Market Cap
$215.78M
Earnings Per Share (EPS)
-0.79
TTM Avg
-1.48
3Y Avg
-1.81
5Y Avg
-1.82
Market Cap
$215.88M
Earnings Per Share (EPS)
-11.77
TTM Avg
-8.68
3Y Avg
-4.76
5Y Avg
-3.49
Market Cap
$189.45M
Earnings Per Share (EPS)
-1.07
TTM Avg
-1.44
3Y Avg
-2.10
5Y Avg
-1.78
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Electra Therapeutics Inc. (ETRA) | $202.90M | N/A | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $208.90M | 4.12 | 3.49 | 2.39 | 2.00 |
| Alector, Inc. (ALEC)vs › | $211.27M | -1.10 | -1.31 | -1.45 | -1.45 |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $193.36M | -0.99 | -0.66 | -3.05 | -5.28 |
| Niagen Bioscience Inc (NAGE)vs › | $214.45M | 0.19 | 0.17 | 0.00 | -0.12 |
| Compugen Ltd. (CGEN)vs › | $215.11M | 0.38 | 0.11 | -0.10 | -0.19 |
| Prelude Therapeutics Incorporated (PRLD)vs › | $215.78M | -0.79 | -1.48 | -1.81 | -1.82 |
| Lyell Immunopharma, Inc. (LYEL)vs › | $215.88M | -11.77 | -8.68 | -4.76 | -3.49 |
| AN2 Therapeutics, Inc. (ANTX)vs › | $189.45M | -1.07 | -1.44 | -2.10 | -1.78 |
| Canton Strategic Holdings Inc (CNTN)vs › | $186.64M | -1.57 | -5.27 | -99.59 | -93.21 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
